Enjoy complimentary customisation on priority with our Enterprise License!
The diuretic drugs market size is forecast to increase by USD 78 million, at a CAGR of 4.5% between 2023 and 2028. The rising trend of hypertension among the global population poses a significant health concern. According to the World Health Organization, approximately 1.13 billion people live with this condition, and this number is projected to increase due to urbanization, sedentary lifestyles, and unhealthy diets. Furthermore, the increasing use of online channels for drug distribution adds another layer of complexity to the issue. This trend is particularly concerning for the geriatric population, who are more likely to have hypertension and require regular medication. As the population ages, the demand for accessible and affordable hypertension treatments through digital platforms is expected to grow. It is essential to ensure the safety and efficacy of these online pharmacies while addressing the underlying causes of hypertension through public health initiatives and education.
For More Highlights About this Report, Request Free Sample
Diuretic drugs are a vital class of medicines used to treat various conditions, including kidney disorders, cardiovascular diseases, and kidney failure. The global market for diuretic drugs is driven by the increasing prevalence of these conditions worldwide. Technologies for improving diuretic drug efficacy and reducing adverse effects are also contributing to market growth. The regulatory framework for diuretic drugs varies by region, with stringent regulations in developed markets and more lenient regulations in localized markets. This can impact the strategic positioning of domestic and international players in the market. Diuretic drugs have several adverse effects, including hypokalemia, hyponatremia, and dehydration. These risks can limit the use of certain diuretics and create opportunities for alternative treatments. Overall, the diuretic drugs market is expected to grow steadily in the coming years, driven by the increasing burden of kidney disorders and cardiovascular diseases. However, the market faces challenges from regulatory hurdles and adverse effects associated with diuretic drugs. The medical community continues to explore advanced treatments for kidney disorder cases, cirrhosis of the liver, and open angle glaucoma therapeutics , aiming to alleviate the burden diseasey of these diseases on global health.
Increasing incidence of hypertension among people is notably driving market growth. Diuretic drugs are essential medications used to treat various kidney disorders, including hypertension, heart failure, and edema. The global market for diuretics is experiencing significant growth due to the increasing prevalence of cardiovascular diseases and kidney failure. According to Data Bridge Market Research, the market value is projected to reach a substantial figure by 2027. The pipeline analysis of diuretic drugs includes advanced technologies such as oral nanoparticle delivery and combination therapies.
However, adverse effects, such as electrolyte imbalance and dehydration, limit the market growth. The regulatory framework for diuretic drugs is stringent due to their potential side effects. Domestic and localized market players are expected to have a strategic impact on the market, especially in regions with high burden diseases. The impact of lockdown measures and lifestyle changes due to the COVID-19 pandemic has affected the sales of diuretic drugs in retail pharmacies. The drug class includes thiazide diuretics, loop diuretics, and potassium-sparing diuretics, which differ in their mechanism of action and route of administration. The patent expiration of major brands, such as those from GlaxoSmithKline, is also impacting the market dynamics. Additionally, the market for diuretic drugs is expanding into genitourinary drugs and hormonal diseases. Thus, such factors are driving the growth of the market during the forecast period.
Increasing kidney diseases is the key trend in the market. The global diuretic drugs market is experiencing significant growth due to the rising prevalence of kidney disorders, particularly chronic kidney disease (CKD). Approximately 10% of the global population is affected by CKD, with millions succumbing to the disease each year due to lack of affordable treatment. In the US alone, 15% of adults or 37 million people are estimated to have kidney disease. The primary cause of CKD is edema, which can be managed effectively with diuretic drugs. The market value for diuretic drugs is expected to increase during the forecast period, driven by advancements in technologies and pipeline analysis.
However, adverse effects associated with long-term use of these drugs can pose a challenge to market growth. The regulatory framework for diuretic drugs is stringent, with companies such as GlaxoSmithKline leading the market. Retail pharmacies and localized market players are also making a significant impact on the market, particularly in developing countries. Oral nanoparticle delivery systems and combination therapies are emerging trends in the diuretic drugs market. The patent expiration of key drugs and the impact of domestic market players are strategic considerations for market players. The diuretic drugs market includes genitourinary drugs and hormonal diseases as key application areas. The route of administration for diuretic drugs includes oral, intravenous, and subcutaneous. The market is expected to be influenced by lifestyle changes, cardiovascular disease, kidney failure, and the burden of disease. Lockdown measures and the economic impact of COVID-19 are also factors that could impact the market dynamics. Thus, such trends will shape the growth of the market during the forecast period.
Price pressure and availability of counterfeiter drugs is the major challenge that affects the growth of the market. The diuretic drugs market is experiencing significant growth due to the increasing prevalence of kidney disorders, particularly in the context of cardiovascular disease and kidney failure. Technological advancements, such as oral nanoparticle delivery systems, are enhancing the efficacy and safety of diuretic drugs. However, adverse effects and the regulatory framework pose challenges to market growth. According to Data Bridge Market Research, the market value is projected to increase at a steady rate, driven by pipeline analysis and the impact of domestic and localized market players.
Further, combination therapies are gaining popularity due to their effectiveness in managing complex kidney disorders. Lockdown measures have had a mixed impact on the market, with some players experiencing increased demand while others face supply chain disruptions. Overall, the diuretic drugs market is a strategic category with intense competition, requiring vendors to continually innovate and differentiate their offerings. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The loop diuretics segment is estimated to witness significant growth during the forecast period. Loop diuretic drugs, a crucial category of genitourinary drugs, play a significant role in managing kidney disorders, particularly those associated with cardiovascular diseases such as heart failure and high blood pressure. These drugs work by inhibiting the sodium-potassium-chloride co-transporter in the thick ascending loop of Henle in the kidneys, leading to increased excretion of chloride, sodium, and potassium. Notable loop diuretics include furosemide, bumetanide, and torasemide, which boast greater bioavailability, longer half-lives, and higher potency compared to other diuretics.
Get a glance at the market share of various regions Download the PDF Sample
The loop diuretics segment accounted for USD 116.20 million in 2018. However, the regulatory framework for diuretic drugs is stringent due to potential adverse effects, such as electrolyte imbalances and dehydration. Moreover, the impact of domestic and localized market players and lockdown measures in various regions may pose strategic challenges to the market's growth. Despite these challenges, the diuretic drugs market holds immense potential, with a robust pipeline analysis and continuous research in hormonal diseases and kidney failure. As the disease burden continues to rise, the demand for effective and safe diuretic drugs will persist.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Diuretic drugs are essential medications used to treat various kidney disorders, including cardiovascular diseases and kidney failure. The market value for diuretic drugs is projected to increase due to the rising burden of diseases such as kidney disorders and hormonal diseases. Technological advancements, including oral nanoparticle delivery systems and combination therapies, are expected to impact the market positively. However, adverse effects associated with long-term use of diuretics may hinder market growth. The regulatory framework for diuretic drugs is stringent due to their potential side effects.
Further, market pipeline analysis indicates several promising drugs in various stages of development. Domestic and localized market players are expected to have a strategic impact on the diuretic drugs market. GlaxoSmithKline, a major player in the genitourinary drugs category, is one of the key contributors to the market. The patent expiration of major diuretic drugs may impact market competition. Lockdown measures and lifestyle changes due to the COVID-19 pandemic may affect the market dynamics. Overall, the diuretic drugs market is expected to grow significantly in the forecast period.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
You may also interested in below market reports:
Diuretic drugs are a crucial category of medications used to treat various kidney disorders, including kidney failure and cardiovascular diseases. The market for diuretic drugs is experiencing significant growth due to the increasing burden of kidney disease and cardiovascular conditions worldwide. Technologies like oral nanoparticle delivery are being explored to enhance the efficacy and reduce adverse effects of these drugs. The market value for diuretic drugs is projected to increase at a steady rate, driven by pipeline analysis and strategic collaborations between key players like GlaxoSmithKline.
However, patent expiration and the entry of localized market players may impact the market dynamics. The regulatory framework for diuretic drugs is stringent due to their potential side effects. Retail pharmacies are a significant distribution channel for these drugs, especially in regions with a high prevalence of kidney disorders and cardiovascular diseases. The impact of lifestyle changes and lockdown measures on the diuretic drugs market is a topic of ongoing research. The market for diuretic drugs also includes genitourinary drugs and hormonal diseases. The drug class can be categorized based on the route of administration, including oral, intravenous, and injectable. Adverse effects of diuretic drugs, such as electrolyte imbalance and dehydration, remain a concern. Combination therapies are being explored to mitigate these side effects and improve patient outcomes. The market for diuretic drugs is expected to continue its growth trajectory, driven by the increasing burden of kidney disorders and cardiovascular diseases.
Market Scope |
|
Report Coverage |
Details |
Page number |
137 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market growth 2024-2028 |
USD 78 million |
Market structure |
Concentrated |
YoY growth 2023-2024(%) |
4.23 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Denmark, China, Canada, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Akorn Operating Co. LLC, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG, and Zydus Lifesciences Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.